VIR
Vir Biotechnology Inc.
$9.61
+$0.44(+4.77%)
53
Overall
60
Value
50
Tech
50
Quality
Market Cap
$720.67M
Volume
1.75M
52W Range
$4.16 - $10.94
Target Price
$20.78
Company Overview
| Mkt Cap | $720.67M | Price | $9.61 |
| Volume | 1.75M | Change | +4.77% |
| P/E Ratio | -1.4 | Open | $9.47 |
| Revenue | $74.2M | Prev Close | $9.17 |
| Net Income | $-522.0M | 52W Range | $4.16 - $10.94 |
| Div Yield | N/A | Target | $20.78 |
| Overall | 53 | Value | 60 |
| Quality | 50 | Technical | 50 |
No chart data available
Latest News
Medivir Calls 2026 AGM, Details Shareholder Voting Procedures and Capital Structure
TipRanks Sweden Auto-Generated Newsdesk•18 hours ago
Goldman Sachs Reaffirms Their Hold Rating on Virtu Financial (VIRT)
TipRanks Auto-Generated Intelligence Newsdesk•a day ago
Goldman Sachs Reaffirms Their Hold Rating on Virtu Financial (VIRT)
TipRanks Auto-Generated Intelligence Newsdesk•a day ago
Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
TipRanks Sweden Auto-Generated Newsdesk•8 days ago
Vidrala Ups Share Buyback to 2% of Capital to Boost EPS
TipRanks Spain Auto-Generated Newsdesk•13 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $9.61 | +4.8% | 1.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |